Clinical efficacy and safety of NAI-Acne gel 3% applied twice-a-day to patients with facial acne vulgaris

Trial Profile

Clinical efficacy and safety of NAI-Acne gel 3% applied twice-a-day to patients with facial acne vulgaris

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2017

At a glance

  • Drugs NAI-Acne (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors NAICONS
  • Most Recent Events

    • 25 Mar 2017 This trial has been completed in Slovakia (end date:11-dec-2015), according to European Clinical Trials Database.
    • 30 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top